The selective estrogen receptor α agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: A phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazine

✍ Scribed by Ronald F. van Vollenhoven; Jos G. A. Houbiers; Frank Buttgereit; Joanna in 't Hout; Maarten Boers; Susanne Leij; Tore K. Kvien; Ben A. C. Dijkmans; Leszek Szczepański; Istvan Szombati; Stanislaw Sierakowski; André M. M. Miltenburg

• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 180 KB
• Volume: 62
• Category: Article
• ISSN: 0004-3591
• DOI: 10.1002/art.27196